Which blood biomarkers actually matter for longevity?

Short answer: several routine and a few specialized blood biomarkers are repeatedly linked to long-term health and mortality risk. Focus first on glucose control, atherogenic lipids (especially particle-based measures), systemic inflammation, kidney/liver function, key micronutrients, and markers of iron/hematologic health. Below I list the most important biomarkers, why they matter, what to watch for, and how to get them tested.

Most important blood biomarkers for longevity (prioritized)

1. Glycemic control

• Tests: Hemoglobin A1c, fasting glucose, fasting insulin (or 2‑hr OGTT if indicated), HOMA‑IR (calculated).
• Why: Chronic high glucose and insulin resistance predict diabetes, cardiovascular disease (CVD) and higher mortality.
• What to aim for: A1c in the normal/low‑normal range (typically <5.7% for non‑diabetics), lower fasting insulin/HOMA‑IR where feasible.
• How to change it: diet (lower refined carbs), weight loss, exercise, sleep, and medications when clinically indicated.

1. Atherogenic lipids and particle measures

• Tests: Standard lipid panel (LDL‑C, HDL‑C, triglycerides) plus Apolipoprotein B (ApoB) and/or LDL particle number (LDL‑P / NMR lipoprofile); Lipoprotein(a) — test once lifetime.
• Why: ApoB and LDL‑P predict cardiovascular risk better than LDL‑C alone. Lp(a) is an inherited major risk factor for CVD.
• What to aim for: Lower ApoB/LDL‑P and LDL; Lp(a) ideally low (but actionable options are more limited—important to know if elevated).
• How to change it: diet, exercise, statins/PCSK9/other meds as appropriate.

1. Systemic inflammation

• Tests: High‑sensitivity C‑reactive protein (hs‑CRP), optional IL‑6, GlycA (advanced).
• Why: Elevated inflammatory markers are strongly linked to higher mortality and CVD risk.
• What to aim for: hs‑CRP <1 mg/L is low risk; >3 mg/L is high risk (context matters).
• How to change it: weight loss, exercise, smoking cessation, Mediterranean-style diet, treatment of underlying causes.

1. Kidney function

• Tests: Serum creatinine with eGFR, cystatin C (more sensitive in some settings), urine albumin/creatinine ratio (UACR).
• Why: Declining kidney function is a major predictor of morbidity and mortality.
• What to aim for: eGFR as high as possible for age; UACR <30 mg/g.
• How to change it: blood pressure and glucose control, medications when indicated.

1. Liver health

• Tests: ALT, AST, GGT, fasting lipid/glucose context; consider hepatic steatosis assessment if abnormal.
• Why: Fatty liver and chronically elevated liver enzymes associate with metabolic disease and higher mortality.
• How to change it: weight loss, exercise, reduce alcohol and refined carbs.

1. Iron and hematologic markers

• Tests: CBC (hemoglobin, hematocrit), ferritin, transferrin saturation, total iron.
• Why: Both anemia and iron overload/high ferritin can increase mortality risk depending on context.
• What to aim for: Hemoglobin in normal range for age/sex; avoid chronically high ferritin without explanation.
• How to change it: correct deficiencies, treat causes of inflammation, therapeutic phlebotomy only when indicated.

1. Vitamin D (25‑OH vitamin D)

• Why: Low 25‑OH vitamin D status is associated with higher all‑cause mortality in many studies; supplementation corrects deficiency.
• What to aim for: Many clinicians target 25‑OH D of ~30–50 ng/mL (discuss with clinician).

1. Thyroid function

• Tests: TSH, free T4 (and free T3 if indicated).
• Why: Both overt and subclinical thyroid dysfunction affect longevity, cardiovascular risk, and metabolic health.

1. Sex hormones (contextual)

• Tests: Total and free testosterone (men), estradiol (women as indicated), SHBG.
• Why: Low testosterone in men and some hormone imbalances in women are linked to frailty, metabolic risk, and mortality—interpret in clinical context.

1. Omega‑3 index (optional, but useful)

• Test: OmegaQuant Omega‑3 Index.
• Why: Higher red‑blood‑cell EPA+DHA levels associate with lower CVD risk and mortality; actionable with diet/supplementation.

1. Cardiac markers in selected patients

• Tests: hs‑Troponin (high‑sensitivity), BNP/NT‑proBNP for heart failure risk.
• Why: Subclinical cardiac injury or elevated natriuretic peptides predict cardiovascular events and mortality in some populations.

1. Advanced/experimental markers (contextual)

• Tests: Epigenetic clocks (DNAm GrimAge, Horvath), telomere length, GlycA, advanced cytokine panels.
• Why: These can provide an “aging” readout but are not yet standard clinical targets—interesting for research/monitoring but not proven to guide therapy yet.

Practical testing — where to get these done (brands/services)

• Quest Diagnostics and LabCorp — widely available clinical labs that run standard tests plus ApoB, Lp(a), cystatin C, NMR lipoprofile (via NMR providers) and more; usually accepted by clinicians/insurance.
• OmegaQuant — gold standard for the Omega‑3 Index blood test.
• InsideTracker and WellnessFX — consumer services that combine lab draws with interpreted, personalized recommendations (good if you want lifestyle-focused guidance).
• TruDiagnostic (and similar services) — for epigenetic age testing (scientific/experimental; useful if you want a DNA methylation age measure).
• Everlywell and LetsGetChecked — convenient at‑home kits for many standard tests (A1c, lipids, vitamin D, basic panels); good for convenience but check which markers they offer.
• Your primary care clinic / preventive cardiology clinic — best place to interpret abnormal results and prescribe interventions.

How often to test

• Baseline full panel: once to establish a personal baseline (including A1c, lipids + ApoB/Lp(a), hs‑CRP, kidney/liver, CBC, ferritin, vitamin D).
• Routine follow‑up: annually for most healthy adults; every 3–6 months if you’re making major changes or being treated for risk factors; sooner if abnormal.

Next steps and cautions

• Prioritize tests that will change management (A1c/glucose, ApoB/Lp(a), hs‑CRP, kidney tests, vitamin D). Lp(a) usually only needs testing once.
• Abnormal results require clinical context—work with a physician, preventive cardiologist, or an experienced clinician to interpret and decide on medications or interventions.
• Lifestyle interventions (weight management, physical activity—especially resistance + aerobic training, Mediterranean/plant‑forward diet, smoking cessation, sleep optimization, stress reduction) improve most biomarkers and are the core longevity strategy.
• Advanced markers (epigenetic clocks, telomere length) are interesting but not yet proven to be intervention targets—use them cautiously.

If you want, I can:

• Suggest a concise lab panel to order based on age/sex/risk factors.
• Recommend which specific providers/labs to use depending on your country and whether you want physician‑ordered tests or at‑home kits.